Endocrine-disrupting chemicals may influence hormonal shifts during pregnancy as well as contribute to postpartum depression, according to a small study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Tag: Endocrine Disruptors
Drug used during pregnancy may increase cancer risk in mother’s adult children
Exposure in the womb to a drug used to prevent miscarriage appears to raise the offspring’s cancer risk decades later, especially for colorectal and prostate cancers, researchers have found. They will present the results of their new study Tuesday at ENDO 2021, the Endocrine Society’s annual meeting.
Propylparaben exposure during pregnancy, breastfeeding may reduce protection against breast cancer
Low doses of propylparaben—an estrogen-like chemical used as a preservative in personal care products and foods—can alter pregnancy-related changes in the breast in ways that may reduce the normal protection against breast cancer that pregnancy hormones convey, according to a new study being published in the Endocrine Society’s journal Endocrinology.
Endocrine Society welcomes European Commission’s chemical strategy
The Endocrine Society welcomed the European Commission’s new Chemical Strategy for Sustainability and its measures to protect the public from endocrine-disrupting chemicals. The communication was released Wednesday as part of the European Green Deal.
Estimating bisphenol exposures in the Australian population
By analyzing urine samples and wastewater, researchers report in ACS’ Environmental Science & Technology how human exposure to bisphenols has changed over time in an Australian population.
Virtual ENDO 2020 news conferences to highlight advances in technology, thyroid health
Researchers will discuss how artificial intelligence and drones are being incorporated into health care when they share the latest emerging science during the Endocrine Society’s ENDO 2020 virtual news conferences March 30-31.